Frontiers in Stroke · Oct 31, 2026
Effects of amlodipine on blood pressure variability in subjects with white matter hyperintensity
By Phillip Ang, Cristian Hernandez, Emma Hall et al.
Background: Blood pressure variability (BPV) is a risk factor for cardiovascular disease, stroke, and cognitive impairment. While medications such as calcium channel blockers may lower BPV, previous studies typically calculate BPV using relatively few blood pressure (BP) readings obtained during outpatient visits. To address this limitation, we used daily at-home BP monitoring to investigate whether amlodipine lowered BPV compared with other antihypertensive medications in patients at risk for vascular cognitive impairment. Methods: We identified subjects over 50 years old without stroke or dementia who had hypertension, were taking BP medications, and had a brain MRI showing at least mild white matter hyperintensity (WMH). BPV was calculated from BP measurements collected for at least 30 days using at-home monitoring devices and defined as the standard deviation of BP. We compared BPV between those taking amlodipine and other antihypertensive medications. P-values <0.05 were considered significant. Results: Among 30 enrolled subjects (15 on amlodipine and 15 not), the mean number of BP measurements was 38 over 31 days. Baseline characteristics were similar between groups. Mean systolic BPV (11.4 vs. 10.5 mmHg, p=0.5) and diastolic BPV (8.47 vs. 8.65 mmHg, p=0.88) did not differ between subjects receiving and not receiving amlodipine. Conclusions: Our prospective pilot study did not detect a significant difference in BPV between participants receiving amlodipine and other antihypertensive medications. However, the limited sample size and statistical power may have prevented detection of smaller differences in BPV. Larger, adequately powered studies are needed to evaluate the relationship between amlodipine and BPV.